Virtus Fund Advisers’s Bio-Techne TECH Stock Holding History

Virtus Fund Advisers’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$301K	Buy	9,296 +3,860	+71%	+$123K	﹤0.01%	454
2017 Q3	$164K	Buy	+5,436	New	+$161K	﹤0.01%	381
2016 Q1	–	Sell	-476	Closed	-$11K	–	730
2015 Q4	$11K	Hold	476	–	–	﹤0.01%	621
2015 Q3	$11K	Hold	476	–	–	﹤0.01%	611
2015 Q2	$12K	Sell	476 -2,476	-84%	-$61.8K	﹤0.01%	625
2015 Q1	$74K	Sell	2,952 -296	-9%	-$7.04K	﹤0.01%	622
2014 Q4	$75K	Hold	3,248	–	–	﹤0.01%	668
2014 Q3	$76K	Sell	3,248 -13,592	-81%	-$319K	﹤0.01%	676
2014 Q2	$390K	Buy	+16,840	New	+$372K	﹤0.01%	757

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtus Fund Advisers's TECH Position: Q4 2017 in Review

Virtus Fund Advisers increased its Bio-Techne (TECH) stake by 71% in Q4 2017, buying an estimated $123K and bringing the position to 9,296 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

Virtus Fund Advisers first reported a position in TECH in Q2 2014 and has held it in 9 quarters since. The position peaked at $390K in Q2 2014. 297 funds tracked by Wall St. Rank hold TECH as of Q4 2017.

Virtus Fund Advisers held 9,296 shares of Bio-Techne worth $301K as of Q4 2017.
Virtus Fund Advisers bought 3,860 Bio-Techne shares in Q4 2017, an estimated $123K.
Bio-Techne made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #454 holding.
Virtus Fund Advisers first reported a position in Bio-Techne in Q2 2014 and has held it in 9 quarters since.
Virtus Fund Advisers's Bio-Techne position peaked at $390K in Q2 2014.
297 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.